Cat. #160703
HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line
Cat. #: 160703
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Peter Bradding ; Harvinder Virk
Institute: University of Leicester
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: HeLa pCDH-CMV-MCS-EF1-copGFP Control Cell Line
- Research fields: Neurobiology
- Tool sub type: Continuous
- Parental cell: HeLa cervical cancer cell line
- Conditional: No
- Description: This cell line is a negative control for the TRPA1 and TRPM2 cell lines developed by Prof Peter Bradding and Dr Harvinder Virk at University of Leicester (see Related tab). This HeLa cell line is stably transfected with the dual-gene promotor pCDH-CMV-MCS-EF1-copGFP vector without carrying a gene of interest.
Target Details
- Target: GFP
Handling
- Format: Frozen
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
Related Tools
- Related tools: Transient receptor potential ankyrin 1 (TRPA1)-GFP HeLa cell line ; Transient receptor potential cation channel superfamily M member 2 (TRPM2)-GFP HeLa cell line
References
- Virk et al. 2019. Sci Rep. 9(1):18500. PMID: 31811235.
